Effects of Scapulathoracic Stabilization Exercises Plus Complex Decongestive Therapy in Women With Lymphedema
Investigation of the Effects of Scapulathoracic Stabilization Exercises Additionally Applied to Complex Decongestive Therapy After Mastectomy on Posture, Balance and Quality of Life
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of the study is to investigate the effects of scapulathoracic stabilization exercises additionally applied to complex decongestive therapy after mastectomy on posture, balance and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2020
CompletedFirst Submitted
Initial submission to the registry
May 29, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedJune 9, 2020
June 1, 2020
8 months
May 29, 2020
June 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Thoracic khyphosis
Thoracic Kyphosis will be evaluated with digital inclinometer device (Baseline® Digital İnclinometer).
change from baseline , at 4 weeks and at 8 weeks
Posture angle
Posture angle will be evaluated with the PostureScreen Mobile (HuaweiTechnologies Co. Ltd, FIG-LX1, Android) application installed on a smartphone
change from baseline , at 4 weeks and at 8 weeks
General posture status
General posture status will be evaluated with the New York Posture Scale, postural changes that can occur in 13 different parts of the body are scored by observing the individual posteriorly and laterally. Each parameter is given 5 if smooth, 3 if moderately impaired, 1 if severely impaired. At the end of the scoring minimum 13, maximum 65 points can be obtained.
change from baseline , at 4 weeks and at 8 weeks
Secondary Outcomes (8)
Balance
change from baseline , at 4 weeks and at 8 weeks
Quality of life outcomes
change from baseline , at 4 weeks and at 8 weeks
The severity of the lymphoedema
change from baseline , at 4 weeks and at 8 weeks
Lymphedema symptoms
change from baseline , at 4 weeks and at 8 weeks
Range of motion of shoulder
change from baseline , at 4 weeks and at 8 weeks
- +3 more secondary outcomes
Study Arms (2)
Exercise+Complex decongestive therapy (CDT) group
EXPERIMENTALThe patients diagnosed with lymphedema with 18-65years of age followed by routine controls and who were volunteered will be included in the study
Only Complex decongestive therapy (CDT) group
ACTIVE COMPARATORThe patients diagnosed with lymphedema with 18-65years of age followed by routine controls and who were volunteered will be included in the study
Interventions
Scapulatoracic stabilization exercises consisted of 3 phases; the warming phase which consists of mobility and stretching; exercise phase consisting of static, dynamic and functional phase; the cooling phase consisting of mobility and stretching. Scapulatoracic stabilization exercises additionally applied to CDT were performed 3 days a week for 8 weeks. These exercises were specially planned for the patients and applied gradually
In the treatment phase of CDT, manual lymph drainage, skin care, compression bandage, draining exercise were applied 5 days a week for 3 weeks. Compression socks, self-drainage, skin care and unloading exercises were applied for 5 weeks in the protection phase of CDT. Thus, patients were followed up with the CDT program for 8 weeks.
Eligibility Criteria
You may qualify if:
- to 65 years of age
- Agree to participate in the study,
- Undergoing unilateral mastectomy due to breast cancer treatment and additionally development of limb lymphedema,
- Lymphedema stage 2 and 3,
- Being a woman,
- Having spent at least 6 months after the operation
- With or without radiotherapy and / or chemotherapy.
You may not qualify if:
- Irregular participation to the treatment program,
- Severe heart failure and / or rhythm disturbance,
- Uncontrolled hypertension,
- Presence of metastasis,
- Infection in the affected arm,
- Any problems that may affect balance (rheumatological, vestibular, visual, neurological),
- Muscular and skeletal system problems (limb shortness, ankle sprain ...), which may affect the balance and posture negatively.
- Presence of spinal deformity,
- Those who have had spinal surgery in the last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Yildirim Beyazit University
Ankara, 06760, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seyda TOPRAK CELENAY
Ankara Yildirim Beyazıt University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 29, 2020
First Posted
June 9, 2020
Study Start
May 20, 2020
Primary Completion
January 1, 2021
Study Completion
June 1, 2021
Last Updated
June 9, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share